Refoxy Pharma
PrivateLast Round
Seed
Dec 4, 2024
Total Funding Raised
$9.56M
Momentum Score
25 /100
Company Overview
Refoxy Pharma is a preclinical biotechnology company developing small molecule activators of the FOXO3 transcription factor for the treatment of age-related diseases, with an initial focus on idiopathic pulmonary fibrosis (IPF).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Refoxy Pharma Comps
Public and private peers based on sector, stage, and business model.
Refoxy Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 4, 2024 | ||||
| Seed | Aug 1, 2021 |
Refoxy Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NRW.Venture | Seed |
| Korify Capital | Seed |
| Boehringer Ingelheim Venture Fund | Seed |
| High-Tech Gründerfonds | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
Monthly visitors grew 300% MoM, reaching 977.
Refoxy Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Refoxy Pharma's valuation, stock price, and market status.
